The Conference Vetting System (CVS) is a unique initiative in the healthcare industry. It is a centralised decision-making system that encourages transparency and consistency in medical education events and alleviates the complex administrative burden previously faced by MedTech Europe and Mecomed members, who were constrained to make their own determinations on whether or not a third-party educational event they wished to provide support to was compliant with the associations’ respective Codes.
CVS is an independently managed system which reviews the compliance of third-party educational events with MedTech Europe Code of Ethical Business Practice and Mecomed Code of Business Practice (the “Codes”) to determine the appropriateness for companies which are members of MedTech Europe and Mecomed to provide financial support to such events in the form of educational grants or commercial activities (booths, advertising, satellite symposium)
Members of MedTech Europe and Mecomed cannot provide support to an event that has not been prior positively assessed by CVS. Furthermore, the decisions rendered by the Compliance Officer are binding on MedTech Europe and Mecomed members. Which means that these members cannot provide support to an event which is found to be not compliant.
The review process is based on a set of 6 criteria that have each the same weight in the evaluation:
The scientific programme, the geographic location, the conference venue, the hospitality, the registration packages benefits, the communication.